AAAAAA
Results:
1-13
|
Results: 13
Authors:
Nikolaus, S
Larisch, R
Beu, M
Vosberg, H
Muller-Gartner, HW
Citation: S. Nikolaus et al., Imaging of striatal dopamine D-2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: A validation study with F-18-(N-methyl)benperidol, J NUCL MED, 42(11), 2001, pp. 1691-1696
Authors:
Hampe, J
Cuthbert, A
Croucher, PJP
Mirza, MM
Mascheretti, S
Fisher, S
Frenzel, H
King, K
Hasselmeyer, A
MacPherson, AJS
Bridger, S
van Deventer, S
Forbes, A
Nikolaus, S
Lennard-Jones, JE
Foelsch, UR
Krawczak, M
Lewis, C
Schreiber, S
Mathew, CG
Citation: J. Hampe et al., Association between insertion mutation in NOD2 gene and Crohn's disease inGerman and British populations, LANCET, 357(9272), 2001, pp. 1925-1928
Authors:
Seegert, D
Rosenstiel, P
Pfahler, H
Pfefferkorn, P
Nikolaus, S
Schreiber, S
Citation: D. Seegert et al., Increased expression of IL-16 in inflammatory bowel disease, GUT, 48(3), 2001, pp. 326-332
Authors:
Schreiber, S
Nikolaus, S
Malchow, H
Kruis, W
Lochs, H
Raedler, A
Hahn, EG
Krummenerl, T
Steinmann, G
Citation: S. Schreiber et al., Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease, GASTROENTY, 120(6), 2001, pp. 1339-1346
Authors:
Nikolaus, S
Huston, JP
Hasenohrl, RU
Citation: S. Nikolaus et al., Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P, NEUROSCI L, 283(1), 2000, pp. 37-40
Authors:
Nikolaus, S
Folsch, UR
Schreiber, S
Citation: S. Nikolaus et al., Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease, HEP-GASTRO, 47(31), 2000, pp. 71-82
Authors:
Hasenohrl, RU
De Souza-Silva, MA
Nikolaus, S
Tomaz, C
Brandao, ML
Schwarting, RKW
Huston, JP
Citation: Ru. Hasenohrl et al., Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery, NEUROPEPTID, 34(5), 2000, pp. 272-280
Authors:
Nikolaus, S
Larisch, R
Beu, M
Vosberg, H
Muller-Gartner, HW
Citation: S. Nikolaus et al., Diffuse cortical reduction of neuronal activity in unipolar major depression: a retrospective analysis of 337 patients and 321 controls, NUCL MED C, 21(12), 2000, pp. 1119-1125
Authors:
Nikolaus, S
Raedler, A
Kuhbacher, T
Sfikas, N
Folsch, UR
Schreiber, S
Citation: S. Nikolaus et al., Mechanisms in failure of infliximab for Crohn's disease, LANCET, 356(9240), 2000, pp. 1475-1479
Authors:
Schreiber, S
Fedorak, RN
Nielsen, OH
Wild, G
Williams, CN
Nikolaus, S
Jacyna, M
Lashner, BA
Gangl, A
Rutgeerts, P
Isaacs, K
Van Deventer, SJH
Koningsberger, JC
Cohard, M
LeBeaut, A
Hanauer, SB
Citation: S. Schreiber et al., Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1461-1472
Authors:
Nikolaus, S
Huston, JP
Hasenohrl, RU
Citation: S. Nikolaus et al., The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection, NEUROREPORT, 10(11), 1999, pp. 2293-2296
Authors:
Schreiber, S
Nikolaus, S
Hampe, J
Hamling, J
Koop, I
Groessner, B
Lochs, H
Raedler, A
Citation: S. Schreiber et al., Tumour necrosis factor a and interleukin 1 beta in relapse of Crohn's disease, LANCET, 353(9151), 1999, pp. 459-461
Authors:
Nikolaus, S
Huston, JP
Hasenohrl, RU
Citation: S. Nikolaus et al., Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor, EUR J PHARM, 370(2), 1999, pp. 93-99
Risultati:
1-13
|